Get the latest delivered to your inbox
Privacy Policy

Now Reading

Gilead Sciences: Living with a Rare Blood Cancer: Marion’s Story

Gilead Sciences: Living with a Rare Blood Cancer: Marion’s Story

Published 06-08-23

Submitted by Gilead Sciences

Marion grew up very healthy, never even getting colds or the flu – but that changed as she got older. 

In her late 50s, Marion’s doctor found a cancerous wart that required an intense six weeks of radiation therapy, coupled with chemotherapy. Then nearly five years later, she was diagnosed with myelodysplastic syndrome (MDS), a rare form of blood cancer that often occurs in people previously treated with radiation or chemotherapy.

A stem cell transplant is usually key to surviving MDS, but due to Marion's age and chronic conditions, she wasn’t a good candidate for a transplant. Instead, her hematologist put her on a medication and she responded well.

Today Marion visits her doctor every four weeks for blood testing and has been treatment-free for more than 18 months.

"I don’t look back,” she says of her experience. “The disease does not define me. I am still me.”

Originally published by Gilead Sciences

Gilead Sciences Logo

Gilead Sciences

Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

More from Gilead Sciences

Join today and get the latest delivered to your inbox